# ACTINIUM PHARMACEUTICALS INC (ATNM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ATNM/

- Reporting holders: 2
- Reported value: $22.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Gerald Baker Financial Group LLC](https://holderbook.com/funds/2133489-gerald-baker-financial-group-llc/) | $22.3K | 19,920 | 0.0% | 3 |
| [Investors Research Corp](https://holderbook.com/funds/1730630-investors-research-corp/) | $336 | 300 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $22.6K |
| Q2 2026 | 51 | $5.3M |
| Q1 2026 | 56 | $5.4M |
| Q4 2025 | 61 | $7.6M |
| Q3 2025 | 62 | $8.4M |
| Q2 2025 | 64 | $7.8M |
| Q1 2025 | 71 | $13.3M |
| Q4 2024 | 71 | $10.3M |
| Q3 2024 | 73 | $16.1M |
| Q2 2024 | 76 | $55.4M |
| Q1 2024 | 67 | $58.5M |
| Q4 2023 | 59 | $30.7M |

